글로벌 연구동향
방사선종양학
- 2018년 12월호[J Neurooncol.] Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study.
성균관의대 / 구태률, 임도훈*2018 Nov댓글: 0조회수: 1059
- 2018년 11월호[Cancer Res Treat.] Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.
서울의대, 성균관의대 / 김규보, 신경환*, 박원*2018 Oct댓글: 0조회수: 1248
- 2018년 11월호[Radiother Oncol.] Comparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: A meta-analysis and systematic review.
고려대 / 임채홍, 윤원섭*2018 Oct댓글: 0조회수: 1197
- 2018년 11월호[Radiother Oncol.] Lung dose and the potential risk of death in postoperative radiation therapy for non-small cell lung cancer: A study using the method of stratified grouping.
아주대 / 허재성, 노오규*2018 Oct댓글: 0조회수: 1253
- 2018년 11월호[Radiother Oncol.] Clinical significance of soluble programmed cell death ligand-1 (sPD-L1) in hepatocellular carcinoma patients treated with radiotherapy.
연세의대 / 김현주, 성진실*2018 Oct댓글: 2조회수: 1273
- 2018년 10월호[Clin Breast Cancer.] Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
성균관의대 / 조원경, 박원*2018 Aug 28. pii: S1526-8209(18)30268-4. doi: 10.1댓글: 1조회수: 1282
- 2018년 10월호[J Breast Cancer.] Patterns of Practice in Radiotherapy for Breast Cancer in Korea.
서울의대 / 박혜진, 오도훈, 신경환*2018 Sep댓글: 1조회수: 1410
- 2018년 10월호[Anticancer Res.] Prediction of Response to Stereotactic Radiosurgery for Brain Metastases Using Convolutional Neural Networks.
KIRAMS / 차유진, 장원일*2018 Sep댓글: 2조회수: 1456
- 2018년 10월호[Radiat Oncol.] Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation.
서울의대 / 김동연, 강현철* 2018 Sep 18댓글: 0조회수: 1237
- 2018년 09월호[Ann Surg.] Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial.
서울대 / 장진영*, 한영민*2018 Aug댓글: 0조회수: 1308